Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer SurgeriesBusiness Wire • 12/13/23
Better Growth Vehicle: Invesco QQQ Trust or Vanguard Information Technology Index Fund?The Motley Fool • 12/06/23
Is Microsoft One of the Best Among Magnificent Seven? ETFs in FocusZacks Investment Research • 11/21/23
This Vanguard ETF Is a Simple Yet Brilliant Way to Invest in Artificial IntelligenceThe Motley Fool • 11/08/23